FDA recall D-0480-2017

Hospira Inc., A Pfizer Company · Class II · drug

Product

METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24

Reason for recall

Lack of Sterility Assurance: customer report of leaking bag

Distribution

Nationwide and Puerto Rico

Key facts

Status: Terminated
Initiation date: 2017-02-10
Report date: 2017-03-01
Termination date: 2019-04-03
Voluntary/Mandated: Voluntary: Firm initiated
Location: Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0480-2017